Mitchell Creinin, MD, University of California, Davis
Background: Medical abortion with mifepristone and misoprostol is highly effective; however, continuing pregnancy can still occur, especially as gestation advances. Even after completing treatment, some women with continuing pregnancies change their mind. Legislators began to focus on women who change their mind after mifepristone administration following a 2012 report of “medical abortion reversal” in which ...Read more >
Alisa Goldberg, MD, MPH, Planned Parenthood League of Massachusetts
Background: Women are seeking abortion at increasingly earlier gestations which increases the likelihood that providers will have difficulty visualizing the pregnancy on ultrasound, the current standard of care in most abortion clinics in the US. Women with no gestational sac visualized on ultrasound have a pregnancy of unknown location (PUL). The most serious risk of ...Read more >
Ushma Upadhyay, PhD, MPH, University of California, San Francisco
Background: New strategies are needed to help people overcome barriers to abortion and achieve greater reproductive autonomy. Demedicalized models for medication abortion care have the potential to greatly expand access to abortion, particularly for those most affected by distance and cost barriers. Methods: The study is a patient-centered, clinically supported, prospective observational study among people ...Read more >
Christopher Ahlbach, BS, University of California, San Francisco
Despite its critical importance in reproductive health, access to safe abortion care in the US and globally continues to be impaired by laws and policies based on religious, political, or other ideologies. Although there is substantial anecdotal evidence about specific beliefs and rationales for opposing abortion provision, identifying specific attitudes, and exploring how those attitudes ...Read more >
Young transgender men (including young people who are transmasculinizing) face disparities in the provision of reproductive health care including contraception, despite their biologic capacity for pregnancy and evidence that this population has a need and desire for these critical services. There is a paucity of evidence describing the contraceptive preferences of transmasculine patients, with almost ...Read more >
Lindsey Yates, MPH, University of North Carolina at Chapel Hill
Black women in the US are more likely to experience unintended and short-interval pregnancies, which are associated with increased risk of adverse birth outcomes for mothers and infants. Long-acting reversible contraception (LARC), including the placement of intrauterine devices (IUDs) or implants, is the most effective contraceptive method for reducing unintended and short-interval pregnancies; however, Black ...Read more >
Motivation for contraceptive use hinges on the user’s assumption that they are fertile—capable of conceiving or impregnating. The idea of infertility carries anxiety and stigma for many and, with no way to validate fertility other than attempting pregnancy, may cause people to doubt their reproductive capacity and need for contraception even though they have no ...Read more >
Renee Kramer, MPH, University of Wisconsin-Madison
Provision of long-acting reversible contraceptives (LARCs) before women leave the delivery hospital can be difficult for health care systems to achieve due to the high costs of devices and insertion. In response to challenges with the global fee for labor and delivery services, 37 states since 2012 have established mechanisms to provide appropriate reimbursement for ...Read more >
This study will examine the experiences of sexual and gender minority (SGM) young people who have had at least one abortion. This study will be innovative by lifting voices of those who are typically excluded from traditional women’s health research and practice. The overall focus of this study will be on understanding SGM young people’s ...Read more >
April J. Bell has designed and implemented data collection and evaluation systems in domestic and international settings. She received her BA in Human Biology from Stanford University, her MPH with a dual concentration in Epidemiology and Social and Behavioral Sciences from the School of Medicine at Indiana University (IU) and is a PhD candidate in ...Read more >
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy